$102.86
+6.84 (+7.12%)
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Price Target
Analyst Price Target
-79.9% upside
Low Target
$16.39
Average Target
$20.70
High Target
$27.30
Current Price
$102.86
Current
$102.86
$102.86
Target
$20.70
$20.70
$16.39
$20.70 avg
$27.30
Scenario Analysis
Bear Case
$16.39
-84.1%
Low target
Base Case
$20.70
-79.9%
Avg target
Bull Case
$27.30
+-73.5%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$115.52
-11.0% from high
52-Week Low
$25.23
+307.7% from low
Target vs 52W High
$20.70
-82.1% vs high
Next Earnings Report
Nov 18, 2026
9d
until earnings
EPS Est: $-0.62
Earnings in 9 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 32% | $149.45 | -41.2% |
| REGN | Buy | 36 | 72% | $76.80 | -91.5% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -40.7% |